| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $210.87M | $22.26M | $39.91M | $61.21M | $52.23M |
| R&D | $26.88M | $6.40M | $23.77M | $48.21M | $38.49M |
| SG&A | $9.69M | $10.50M | $12.69M | $13.00M | $13.74M |
| Operating Income | -$210.87M | -$22.26M | -$39.91M | -$61.21M | -$52.23M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $50.00K | $41.00K | $0.00 | $0.00 | $0.00 |
| Net Income | -$209.84M | -$21.44M | -$38.35M | -$61.62M | -$51.75M |
| EPS (basic) | 3.9800 | -18.5300 | -1.4400 | -2.4300 | -2.0500 |
| EPS (diluted) | 3.9800 | -18.5300 | -1.4400 | -2.4300 | -2.0500 |
| Shares (diluted) | $1.36M | $1.16M | $26.57M | $25.41M | $25.26M |